superficial esophageal cancers
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Relative adaptational lesion for ESD and more than 3/4 luminal circumferencial mucosal defect
Exclusion criteria
Exclusion criteria: 1)Not acceptance to participate in the study 2)Allergy for triamcinolone acetonide 3)Severe DM or adrenal malfunction 4)Inappropriate for this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the treatment duration between 2 groups (the weekly group receive 40mg of triamcinolone acetonide weekly, the biweekly group receive 40mg of triamcinolone acetonide biweekly ) | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of EBD(endoscopic balloon dilations), Stricture rate, Frequency of adverse events | — |
Countries
Japan
Contacts
Kobe University, School fo Medicine Department of Gastroenterology